This website uses cookies

We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will only use cookies based on your decision.

Breast Cancer

The serum HER-2/neu Test and Metastatic Breast Cancer

Serum HER-2

serum HER-2/neu: Helping Women with Metastatic Breast Cancer

The serum HER-2/neu test is a simple blood test for over 150,000 women living with metastatic breast cancer.1 For the thousands of women diagnosed with metastatic breast cancer each year, the Siemens serum HER-2/neu test is the automated serum HER-2/neu test available for sale in the U.S. for monitoring their Serum HER-2/neu status during therapy. The serum HER-2/neu test is indicated for follow-up and monitoring patients with metastatic breast cancer and initial serum level >15 ng/mL.
 

serum HER-2/neu Status: Providing Critical Information for Metastatic Disease Assessment

Less than 15% increase is considered to indicate a lack of progression. Increase of equal or greater than 15% was considered to indicate progression.*

Monitoring serum HER-2/neu levels yields important information about response to therapy and cancer progression, and may help physicians make more informed decisions when developing and modifying patient treatment regimen. 2-4  



2
3
4
Subscription Button Icon
Be the first to know about our events, training, and news